Skip to main content
OpenTrials
Completed

NCT Number: NCT02888288

Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth

The purpose of this study is to evaluate if a group-based mental health intervention called Sauti ya Vijana (The Voice of Youth) designed to address mental health challenges faced by adolescents in Tanzania is acceptable and feasible and if it improves mental health, antiretroviral therapy (ART) adherence, and virologic outcomes among HIV-positive adolescents as compared to youth receiving treatment as usual. Mental health intervention sessions will take place three times a month for approximately four months in groups of eight to ten youth based on age and sex. Caregivers will attend two sessions to support the youth and provide the guardian perspective on caring for HIV-positive adolescents. The investigator hypothesizes the mental health intervention will be acceptable, feasible, and will improve mental health and ART adherence among participating youth and this improvement will be sustained over time.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The study will enroll up to approximately 130 participants from the established Kilimanjaro Christian Medical Centre and Mawenzi Saturday Teen Clinics. Participants will be assigned to approximately eight to ten persons per group, based on age and sex. Groups will be matched in pairs as closely as possible (ex. two groups of females 12-16 years of age) and assigned to Wave 1, 2, or 3. Randomization will occur on the individual level and will occur just before the start of mental health intervention for each wave. Individuals will be randomized at this time point to reduce potential drop out of those with delayed start (Wave 2/3). Randomization will occur by a coin flip for two individuals based on alphabetical order: heads will be intervention group (I) and tails the standard of care group (SOC).

This feasibility study is longitudinal with up to 24 month follow-up after intervention. Feasibility measures from lay counselors will be monitored weekly. Outcome measures will be obtained by blinded interviewers using a structured survey to inquire about mental health symptoms, self-report adherence, obtain an ART drug concentration level from a hair sample, and HIV-1 viral load from a blood sample and will be collected by the same research assistants at five to six potential time points: 1) baseline, 2) pre-intervention, 3) post-intervention, 4) 6-months post-intervention, 5) 12-months post-intervention and 6) 24-months post-intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Youth between the ages of 12 and 24 years of age, attending the Teen Club HIV clinic at Kilimanjaro Christian Medical Centre (KCMC) and/or Mawenzi Hospital and receiving ART
  • if > or =l to 18 years, able to understand the project and provide written, informed consent
  • if < 18 years, a parent or guardian must provide written permission and participant must be able to assent
  • all adolescents must also commit to attending 10 weekly CBT (SYV) sessions and 2 individual sessions.

Exclusion criteria

  • Active psychosis, developmental delay, or cognitive disability that precludes active participation in consent process, intervention, and assessment interviews.

Treatment and study plan

Mental Health Intervention

Behavioral

Includes a standard format of greetings, review of last session content, homework discussion, new topic, assigning homework and ends with a fun activity, relaxation or game. First session is a joint session with youth and caregivers. Topics include common stresses and worries experienced by HIV+ youth; relaxation and coping techniques; cognitive behavioral triangle; story of finding out HIV status and if willing, to discuss this in an individual session, peer group session, and with caregiver; identify circles of support; discuss stigma and how to disclose HIV status to others; consider values, hopes and dreams for the future, and how to use this information to live positively with HIV. ART adherence is woven into case examples and discussions.

Standard of Care

Behavioral

Standard of Care includes enhanced ART adherence based on clinic protocols and monthly HIV teaching sessions prior to adolescent clinic.

Primary outcomes

  1. Participant attendance

    Time frame: weekly for 16 weeks during each intervention wave (over 2 years)

    Measure the percentage of participants who complete all intervention sessions and ability to interview participants for outcome measures over time.

  2. Caregiver participation as measured by questionnaire

    Time frame: during 2 caregiver sessions

    Record willingness of caregivers to participate (if unwilling, why not) and attendance.

  3. Caregiver participation as measured by attendance sheet

    Time frame: during 2 caregiver sessions

  4. Fidelity as measured by weekly supervisor meeting

    Time frame: weekly for 16 weeks during the intervention wave (over 2 years)

  5. Fidelity as measured by fidelity checklists

    Time frame: weekly for 16 weeks during the intervention wave (over 2 years)

Secondary outcomes

  1. Change in Mental Health

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

    Compare the change in standard deviation of mental health symptoms on the PHQ-9, between the intervention group versus SOC.

  2. Change in Mental Health

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

    Compare the change in standard deviation of mental health symptoms on the SDQ, between the intervention group versus SOC.

  3. Change in Mental Health

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

    Compare the change in standard deviation of mental health symptoms on the UCLA PTSD-RI, between the intervention group versus SOC.

  4. Change in ART adherence

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

    Compare the change in self-report adherence between the intervention group versus SOC.

  5. Change in virologic outcomes

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

    Describe the proportion of youth with viral suppression (HIV-1 RNA < 400 copies/ml) in the intervention group and SOC.

  6. Compare method of adherence measurement

    Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention

    Compare self-report ART adherence with drug level concentration of hair samples.

  7. Change in mental health (individual)

    Time frame: baseline to post-intervention, 6-, 12-,18- and 24-months

    Compare the change in standard deviation of mental health symptoms on the PHQ-9, SDQ, UCLA PTSD-RI at the individual level.

  8. Change in adherence (individual)

    Time frame: baseline to post-intervention, 6-, 12-, and 24-months

    Compare the change in self-reported adherence and antiretroviral drug concentration in hair.

  9. Change in HIV viral load (individual)

    Time frame: baseline to post-intervention, 6-, 12-, and 24-months

    Compare the change in HIV viral load.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Kilimanjaro Christian Medical Centre, Tanzania

Registry information

Important dates

Study start
2016
Primary completion
2020
Study completion
2020
First posted
Sep 5, 2016
Registry last updated
Oct 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.